BeOne Medicines (ONC) Other Operating Expenses (2017 - 2023)
BeOne Medicines (ONC) posted quarterly Other Operating Expenses of $188000.0 for Q2 2023, down 99.74% year-over-year from $71.4 million in Q2 2022, and up 0.53% quarter-over-quarter from $187000.0 in Q1 2023.
BeOne Medicines (ONC) Other Operating Expenses (2017 - 2023) Analysis & Trends
BeOne Medicines (ONC) has reported Other Operating Expenses for 7 consecutive years, with $188000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Other Operating Expenses fell 99.74% year-over-year to $188000.0; the TTM figure through Mar 2024 stood at $188000.0 (up 100.29% YoY), while the FY2020 annual figure was $71.5 million, down 1.4% from the prior year.
- Other Operating Expenses grew to $188000.0 in Q2 2023 per ONC's latest filing, from $187000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $76.7 million in Q3 2022 and bottomed at -$213.5 million in Q4 2022.
- Historically, Other Operating Expenses has averaged $8.0 million across 5 years, with a median of $19.4 million in 2019.
- Annual changes were most pronounced in 2019 — Other Operating Expenses soared 229.08% — and 2021, when it tumbled 649.82%.
- BeOne Medicines' Other Operating Expenses stood at $18.3 million in 2019, then increased by 16.11% to $21.3 million in 2020, then sank by 649.82% to -$116.9 million in 2021, then plunged by 82.61% to -$213.5 million in 2022, then surged by 100.09% to $188000.0 in 2023.
- Business Quant data shows ONC's Other Operating Expenses at $188000.0 in Q2 2023, $187000.0 in Q1 2023, and -$213.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 188,000.00 |
| Mar 31, 2023 | 187,000.00 |
| Dec 31, 2022 | -213.52 Mn |
| Sep 30, 2022 | 76.73 Mn |
| Jun 30, 2022 | 71.36 Mn |
| Mar 31, 2022 | 65.43 Mn |
| Dec 31, 2021 | -116.92 Mn |
| Sep 30, 2021 | 47.60 Mn |
| Jun 30, 2021 | 36.45 Mn |
| Mar 31, 2021 | 32.87 Mn |
| Dec 31, 2020 | 21.27 Mn |
| Sep 30, 2020 | 21.31 Mn |
| Jun 30, 2020 | 14.50 Mn |
| Mar 31, 2020 | 14.43 Mn |
| Dec 31, 2019 | 18.32 Mn |
| Sep 30, 2019 | 20.44 Mn |
| Jun 30, 2019 | 18.17 Mn |
| Mar 31, 2019 | 15.59 Mn |
| Dec 31, 2018 | 9.52 Mn |
| Sep 30, 2018 | 8.89 Mn |